Healthy Control Population for PAIS-ME/CFS: Study to Evaluate Possible Biomarkers and Methods for Examination of PAIS-ME/CFS Diagnostics in Healthy Volunteers
Launched by TECHNICAL UNIVERSITY OF MUNICH · Oct 20, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to study healthy individuals to better understand two complex conditions known as ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and PAIS (Post-Acute Infection Syndrome). Researchers want to compare data from healthy volunteers with information from patients who have these conditions. By doing this, they hope to find specific patterns or markers that could help in diagnosing these diseases and developing new treatments.
To participate in the study, you need to be between the ages of 10 and 25 and generally healthy, meaning you shouldn't have any major medical issues, except for mild conditions like asthma or allergies that don’t require regular medication. If you’re a minor, you'll need permission from a parent or guardian. Participants will not be able to take certain medications or have had recent surgeries or infections before the study. If you join, you will help researchers gain valuable insights that could lead to better care for those suffering from ME/CFS and PAIS in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy control subjects without a known medical diagnosis, except: asthma, allergies, neurodermatitis, if this does not require regular medication (self-disclosure)
- • Age: 10 - 25 years
- • Written declaration of consent or, in the case of minors, written declaration of consent from the participants and their legal representatives
- Exclusion Criteria:
- • Acute illnesses (e.g. infections) or major injuries
- • Known chronic diseases (including psychological diagnoses) other than those mentioned above
- • Surgery or blood transfusion in the last 3 months
- • No intake of on-demand medication (e.g. painkillers) in the last 7 days before the date of the examination
- • Pregnancy; Breastfeeding
- • Limited legal capacity
About Technical University Of Munich
The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported